Human papillomavirus vaccination programmes

Vaccination against human papillomavirus

Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.

Human papillomavirus vaccination.

Human Papillomavirus Vaccination Strategies

with no adverse effects reported. One patient treated herself with albendazole (400 mg/day for 3 days) before she was seen at a hospital. All patients became asymptomatic and had negative stool examination results 2–10 weeks after treatment. None of the patients reported previous or subsequent consumption of raw freshwater fi sh. Raw fi sh preparations such as sushi, sashimi, carpaccio, and cev...

Preventive human papillomavirus vaccination.

Therapeutic human papillomavirus vaccination.

Despite impressive progress in prevention and therapy of premalignant and malignant dysplasia the worldwide burden of cancer is relatively unchanged. Supplementation of the therapeutic arsenal by immunotherapeutic methods would have the potential to make a significant impact. Dysplastic lesions and cancer of the cervix show strong association with human papillomaviruses (HPV), as do tumours of ...